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structures. Fluorescently labeled HDL was transported 
into close proximity of BC-like structures, whereas HDL 
labeled with the fluorescent cholesterol analog BODIPY-
cholesterol was clearly detected within these structures. 
Importantly, similarly to human and mouse liver, SR-BI 
was localized in basolateral membranes in three-dimen-
sional liver microtissues from primary human liver cells. 
Our results demonstrate that SR-BI is highly enriched 
in sinusoidal membranes and is also found in canalicular 
membranes. There was no significant basolateral–apical 
redistribution of hepatic SR-BI in fasting and refeeding 
experiments in mice. Furthermore, in vitro studies in polar-
ized HepG2 cells showed explicit differences as SR-BI was 
highly enriched in BC-like structures. These structures are, 
however, functional and accumulated HDL-derived choles-
terol. Thus, biological relevant model systems should be 
employed when investigating SR-BI distribution in vitro.
Keywords SR-BI · Cholesterol · HDL · Canalicular 
membranes · HepG2 · BODIPY-cholesterol
Abbreviations
3D  Three-dimensional
ABCB11  ATP-binding cassette transporter B11
BC-like  Bile canalicular-like
BP-C  BODIPY-cholesterol
CETP  Cholesteryl ester transfer protein
HDL  High-density lipoprotein
LDL  Low-density lipoprotein
LDLR  LDL receptor
MDR1  Multidrug resistance protein 1
MRP2  Multidrug resistance-associated protein 2
PDZK1  PDZ domain-containing protein 1
SR-BI  Scavenger receptor, class B, type I
VLDL  Very low-density lipoprotein
Abstract The high-density lipoprotein (HDL) receptor, 
scavenger receptor class B, type I (SR-BI), mediates selec-
tive cholesteryl ester uptake into the liver, which finally 
results in cholesterol secretion into the bile. Despite sev-
eral reports, the distribution of hepatic SR-BI between 
the sinusoidal and canalicular membranes is still under 
debate. We present immunohistological data using spe-
cific markers showing that the bulk of SR-BI is present 
in sinusoidal membranes and, to a lesser extent, in cana-
licular membranes in murine and human liver sections. In 
addition, SR-BI was detected in preparations of rat liver 
canalicular membranes. We also compared the in vivo 
findings to HepG2 cells, a widely used in vitro hepato-
cyte model. Interestingly, SR-BI was enriched in bile 
canalicular-like (BC-like) structures in polarized HepG2 
cells, which were cultivated either conventionally to form 
a monolayer or in Matrigel to form three-dimensional 
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Introduction
The scavenger receptor class B, type I (SR-BI), a cell 
surface glycoprotein that binds high-density lipoprotein 
(HDL), low-density lipoprotein (LDL), very low-density 
lipoprotein (VLDL), modified LDL, and anionic phospho-
lipid (Acton et al. 1994, 1996; Rigotti et al. 1995; Calvo 
et al. 1997), mediates the last step in reverse cholesterol 
transport, namely the delivery of cholesteryl esters and 
other lipids from HDL to liver cells for disposal into the 
bile. This process, in which HDL- and LDL-derived cho-
lesteryl esters are transferred to the cell without the con-
comitant degradation of the lipoprotein particle, is termed 
selective cholesteryl ester uptake (Acton et al. 1996; Glass 
et al. 1983, 1985; Stangl et al. 1998, 1999; Swarnakar et al. 
1998). Of all organs, SR-BI expression is most abundant in 
the liver (Krieger 1999). Consequently, the liver accounts 
for up to 90 % of selective HDL cholesteryl ester uptake 
in rats and mice (Glass et al. 1983, 1985; Stein et al. 1983; 
Pittman and Steinberg 1984; Knecht and Pittman 1989). 
As expected, less selective cholesteryl ester uptake from 
HDL particles (~20 %) is found in the liver of cholesteryl 
ester transfer protein (CETP)-expressing animals (Gold-
berg et al. 1991). Hepatic SR-BI expression is regulated by 
dietary, hormonal, and pharmacological interventions; for 
reviews see (Kent and Stylianou 2011) (Landschulz et al. 
1996; Fluiter et al. 1998; Serougne et al. 1999).
There is a puzzling discrepancy about the reports on 
the localization of hepatic SR-BI: Under basal condi-
tions, most hepatic SR-BI resides on parenchymal cells 
(Fluiter et al. 1998; Stangl et al. 2002; Mardones et al. 
2003) and is most exclusively located on the sinusoidal 
surface of hepatocytes (Mardones et al. 2003; Stangl et al. 
2002). However, in mice overexpressing SR-BI, SR-BI 
was detected in the canalicular domains of hepatocytes 
by immunohistochemistry (Kozarsky et al. 1997; Ikemoto 
et al. 2000; Sehayek et al. 2003). SR-BI was also detected 
on cultured hepatocyte couplets using WIF-B9 cells (Sil-
ver et al. 2001). In addition to its expression in liver paren-
chymal cells, SR-BI protein has been detected in Kupffer 
(Fluiter et al. 1998; Hoekstra et al. 2005; Malerod et al. 
2002) and liver endothelial cells (Hoekstra et al. 2005; 
Malerod et al. 2002). Interestingly, an atherogenic diet 
was shown to induce SR-BI expression several fold in 
Kupffer cells (Fluiter et al. 1998; Hoekstra et al. 2005) and 
to a much lesser extent in liver parenchymal and endothe-
lial cells in mice. However, the precise role of SR-BI in 
Kupffer cells remains to be elucidated.
Several lines of evidence demonstrate that SR-BI is 
redistributed between apical and basolateral membranes as 
a function of their cholesterol levels. For example, Harder 
et al. (2007) showed that SR-BI undergoes transcytosis 
to apical bile canalicular-like (BC-like) structures upon 
cholesterol loading in polarized hepatocytes (WIF-B cells). 
Conversely, transcytosis of SR-BI was observed upon cho-
lesterol depletion in MDCK cells (Burgos et al. 2004). 
These data indicate regulated apical–basolateral cell sur-
face protein distribution in cell models.
Since the liver is characterized by a rather complex 
polarity, the question still remains how SR-BI is distributed 
between sinusoidal and canalicular membranes. To clarify 
this, we investigated the localization of SR-BI protein in 
human and rodent liver sections. We employed immunohis-
tological, biochemical, and cell biological methods to show 
the expression of SR-BI in sinusoidal membranes and to a 
lesser extent in canalicular membranes.
Materials and methods
Antibodies
The following antibodies were used: anti-MDR1 (ABCB1; 
Kamiya Biomedical Company, USA) 1:200; anti-ABCB11 
(BSEP; Santa Cruz, USA) 1:50; anti-MRP2 (ABCC2; 
Enzo Life Sciences, USA) 1:50; anti-β-catenin (Life 
Technologies, USA) 1:500; anti-SR-BI (CLA-1; BD Bio-
sciences, USA) 1:50 for HepG2 cells; anti-SRBI (Stangl 
et al. 1998) 1:200 for mouse liver and HepG2, Huh7 and 
human liver microtissues; anti-SRBI (kindly provided 
by A. Ritsch, Med. Univ. Innsbruck, Austria) 1:200 for 
human liver; anti-LAP (kindly provided by A. Rigotti, 
Universidad Católica de Chile, Santiago, Chile); anti-
LDLR (kindly provided by M.S. Brown and J.L. Gold-
stein, UTSW, Dallas, TX).
Cell culture
HepG2 cells were maintained in minimal essential medium 
(MEM, GE Healthcare, UK) supplemented with 10 % 
fetal bovine serum (FBS; Gibco, Life Technologies), 1 % 
nonessential amino acid solution (Sigma, USA), 1 mM 
sodium pyruvate (PAA, Austria), and penicillin/streptomy-
cin (PAA). For microscopy on HepG2 monolayers, cells 
were grown on coverslips in 24-well plates at a density of 
2 × 105 cells/well.
HepG2 spheroid formation and harvesting
A single cell suspension of HepG2 cells (~6 × 103 cells/
ml) in cold medium was mixed 1:3 with Matrigel (Base-
ment Membrane Matrix Growth Factor Reduced; BD Bio-
sciences). From this suspension, aliquots of 50 µl were 
placed into the middle of 24 wells. Plates were incubated at 
37 °C for 30 min until the Matrigel was gelled. Then, warm 
medium was added. On day 4, HepG2 spheroids were 
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harvested using a cell recovery solution (Corning, USA) 
according to the manufacturer’s protocol.
Lipoprotein isolation and labeling with fluorescent dyes
Plasma was collected from healthy volunteers, and HDL 
was prepared by sequential ultracentrifugation (d = 1.21 g/
ml) (Schumaker and Puppione 1986). The apolipoprotein 
part of HDL was covalently labeled with Alexa Fluor 488 
(Molecular Probes, USA) according to the manufacturer’s 
instructions. Loading of HDL with BODIPY-cholesterol 
(BP-C) (Li et al. 2006) was performed as described previ-
ously (Rohrl et al. 2012). HepG2 cells were incubated with 
50 µg/ml of labeled HDL for the indicated time points. 
Thereafter, cells were fixed in 4 % formaldehyde at 4 °C 
for 30 min, and samples were mounted and examined using 
a confocal microscope (LSM 5 Exciter, Zeiss, Germany).
TRITC-phalloidin staining
The TRITC-phalloidin (Sigma) stock solution of 0.1 mg/ml 
in DMSO was diluted 1:500 in PBS. After fixation, HepG2 
cells were washed twice with PBS, incubated with the 
phalloidin working solution for 20 min at room tempera-
ture, and washed twice with PBS.
Immunofluorescence on HepG2 monolayers and spheroids
HepG2 cells were fixed in 4 % formaldehyde at 4 °C for 
30 min. Samples were then washed twice with PBS and 
blocked with PBS containing 2 % BSA (Sigma) and 0.05 % 
saponin (Sigma) at room temperature for 1 h, followed by 
incubation with primary antibodies diluted in PBS contain-
ing 1 % BSA and 0.05 % saponin (buffer A). After harvest-
ing and fixation in 4 % formaldehyde at 4 °C for 30 min, 
HepG2 spheroids were blocked with PBS containing 5 % 
BSA and 1 % Triton-X100 (Sigma) (buffer B) at room 
temperature for 1 h and incubated with primary antibod-
ies diluted in buffer B overnight at 4 °C. Next, cells were 
washed twice with PBS and incubated with secondary anti-
bodies diluted in buffer A (HepG2 monolayers) or buffer B 
(HepG2 spheroids) at room temperature for 1 h. Thereafter, 
cells were washed twice with PBS, and phalloidin staining 
and counter staining using DAPI were performed. The sam-
ples were mounted with Fluoprep (Biomerieux, France) 
and imaged using a fluorescence microscope (Axiovert 
135, Zeiss) or a confocal microscope (LSM 5 Exciter).
HepG2 and Huh7 liver microtissue production and culture
Paraffin sections from 3D InSight™ HepG2 and Huh7 liver 
microtissues were obtained from InSphero AG (Schlieren, 
Switzerland). The cells were seeded in hanging-drop plates 
(GravityPLUS™) for microtissue re-aggregation and fur-
ther cultivated in GravityTRAP™ plates in 3D InSight™ 
HepG2 Liver Maintenance Medium (InSphero AG). The 
tissues were cultivated for 14 days before formalin fixation 
and paraffin embedding. Paraffin sections were processed 
similarly as mouse liver sections.
Human liver microtissue production and culture
Paraffin sections from 3D InSight™ Human Liver Micro-
tissues were obtained from InSphero AG. The liver micro-
tissues consisted of primary human hepatocytes (lot IZT) 
in co-culture with primary non-parenchymal cells (lot JJB). 
The mixture of primary human liver cells were seeded in 
hanging-drop plates (GravityPLUS™) for microtissue 
re-aggregation and further cultivated in GravityTRAP™ 
plates in 3D InSight™ Human Liver Maintenance Medium 
(InSphero AG). The tissues were cultivated for the indi-
cated time points and harvested for histology. Formalin-
fixed microtissues were paraffin embedded, sectioned, and 
processed similarly as mouse liver sections.
Immunofluorescence on human and mouse liver sections
Normal human liver sections were obtained from US Bio-
max (USA). Mouse liver samples were retrieved from 
11-week-old male C57BL/6 J mice. All protocols for ani-
mal use and experiments were reviewed and approved 
by the Austrian Ministry of Science and Research. Mice 
were kept on chow under standard conditions and had free 
access to food and water. After transcardial perfusion with 
PBS, the liver was collected, fixed in 4.5 % formaldehyde 
for 24 h, and afterward paraffin embedded. Human and 
mouse liver sections were processed similarly, and depar-
affinization and antigen retrieval were conducted accord-
ing to standard procedures. Afterward, liver sections were 
washed twice with TBS, blocked in TBS containing 5 % 
BSA (buffer C) at room temperature for 1 h, followed by 
incubation with primary antibodies diluted in buffer C at 
4 °C overnight. Samples were washed twice with TBS and 
incubated with secondary antibodies diluted in buffer C at 
room temperature for 1 h. The procedure was adapted for 
the primary mouse anti-MRP2 and mouse anti-β-catenin 
antibodies on mouse tissue using the M.O.M.-Kit (Vec-
tor Laboratories, USA) according to the manufacturer’s 
instructions. Finally, samples were washed twice with 
TBS, DAPI stained, washed twice with TBS, and mounted 
using Fluoprep. Liver sections were imaged using a con-
focal microscope (LSM 5 Exciter). Images of the fasting–
refeeding experiment were taken with a Leica SP2-AOBS 
confocal laser scanning microscope. Fluorescent dyes were 
imaged sequentially in frame interlace mode to eliminate 
cross talk between the channels.
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Fasting and refeeding experiments
Ten-week-old male C57BL/6 J mice were obtained from 
Elevage Janvier (France) and were acclimatized to local 
animal facility conditions for two weeks prior to the fast-
ing and refeeding experiment. Mice were housed at 22 °C 
with a 12/12-h light/dark cycle (lights on at 6 a.m. and off 
at 6 p.m.) and provided water and standard rodent chow 
diet ad libitum. Mice were randomly assigned to the exper-
imental groups. For the fasting and refeeding experiment, 
mice were either used in the ad libitum fed state or fasted 
for 24 h, or fasted for 24 h and subsequently refed with 
a standard chow diet for 12 h. Mice were killed at 9 a.m. 
Mice were anesthetized with ketamine hydrochloride and 
xylazine, and the liver was perfused with PBS for 2 min 
and subsequently with 4 % formaldehyde. The fasting–
refeeding experiments were reviewed and approved by the 
Veterinary Office of Zürich (Switzerland).
Preparation of rat liver canalicular plasma membranes
Canalicular membranes were prepared according to Inoue 
et al. (1983a, b): Aliquots of the intermediate steps were 
kept to monitor the distribution of the proteins and enzyme 
activities and estimate their enrichment or depletion. Male 
Sprague–Dawley rats, 200–250 g, were kept on stand-
ard chow and housed at a light–darkness cycle of 12 h in 
the animal facility (Stangl et al. 2002). Rats were anes-
thetized, and their livers were perfused in situ with 30 ml 
of ice-cold saline and subsequently with 20 ml of 0.25 M 
sucrose, 10 mM Hepes-Tris buffer, pH 7.4, and 0.2 mM 
CaCl2 (medium A). The liver was excised, minced, and 
homogenized with 30 strokes in medium A (60 ml/12.5 g 
liver weight) using a loose fitting Dounce homogenizer 
(Sigma) at 0 °C. After filtration through cheesecloth (Ali-
quot S1), the homogenate was diluted to 160 ml with ice-
cold medium A with 1 mM EDTA. After centrifugation for 
10 min at 1,800g, the pellet and fluffy layer were collected 
and resuspended in 80 ml of medium A (Aliquot S2). The 
sample was re-centrifuged at 3,000g for 10 min. The pellet 
was suspended in 30 ml of medium A, placed in a high-
pressure chamber (Parr Instrument, USA), and equilibrated 
with nitrogen at 800 psi for 15 min with gentle stirring at 
0 °C. Then, the pressure was suddenly released and 95 ml 
of ice-cold medium A containing 14 mM CaCl2 was added 
to the homogenate, and the mixture was stirred gently for 
10 min (Aliquot SA). After centrifugation for 20 min at 
7,600g, the supernatant was collected (Aliquot SB) and 
centrifuged for 20 min at 47,000g (Aliquot SC). The result-
ing pellet was resuspended in 8 ml of ice-cold medium 
A and again centrifuged at 47,000g for 30 min (Aliquot 
CM). The resulting pellet was resuspended in about 200 µl 
of medium A using a syringe and needle (26 gauge) and 
afterward stored at −80 °C for Western blot analysis. Enzy-
matic analysis of 5′-nucleosidase and acid and alkaline 
phosphatase was performed using freshly prepared samples 
using standard test kits from Sigma.
Results
SR-BI is localized to BC-like structures in human 
hepatoma cell lines
Primary hepatocytes lose their polarity within hours (Tsu-
kamoto et al. 2013; Graf et al. 1984), but some hepatocyte 
couplets form BC-like structures (Graf et al. 1984). Simi-
larly, human hepatoma cell lines are capable of forming BC-
like structures (Sormunen et al. 1993; Chiu et al. 1990). In 
HepG2 cells, such BC-like structures, which are surrounded 
by actin filaments as shown by phalloidin staining, were 
detected (Supplementary Fig. 1). These BC-like structures 
exhibited a strong co-localization of phalloidin and multid-
rug resistance protein 1 (MDR1), an efflux transporter local-
ized to the apical canalicular membrane in the liver. Thus, 
phalloidin staining is an appropriate marker of these struc-
tures in this in vitro model and was used to identify BC-like 
formations. SR-BI was enriched at the apical side of HepG2 
cells (Fig. 1a, upper panel) and co-localization with phalloi-
din was regularly detected (see insert), indicating that SR-BI 
is in part localized at BC-like structures in HepG2 cells.
We next sought to compare the HepG2 monolayer cul-
ture with a more physiological three-dimensional (3D) 
model. Therefore, HepG2 cells were cultivated in Matrigel 
and allowed to form spheroids (Fig. 1a, lower panel). In 
HepG2 monolayers and spheroids, SR-BI was detected 
at the cell membrane and co-localized with phalloidin, 
indicating that SR-BI is localized to BC-like structures in 
HepG2 cells independent of the culturing conditions. Next, 
we compared the localization of SR-BI in HepG2 and 
Huh7 microtissues with 3D human liver microtissues, all 
of which were established using the hanging-drop culture 
(Supplementary Fig. 2). SR-BI was localized to the plasma 
membrane in HepG2 (Supplementary Fig. 2a) and Huh7 
(Supplementary Fig. 2b) microtissues with enrichment in 
BC-like structures (compare with Fig. 1). 3D human liver 
microtissues generated from primary human parenchymal 
cells (hepatocytes) and liver-derived non-parenchymal cells 
have been shown to retain long-term viability and function-
ality in culture (Messner et al. 2013). Immunofluorescence 
analysis revealed that SR-BI is localized to the plasma 
membrane in 3D human liver microtissues (Supplementary 
Fig. 2c). SR-BI distribution did not differ between microtis-
sues that were cultured for 7, 14, 21, or 28 days. Our data, 
along with previously published data showing the distribu-
tion of apical markers in liver microtissues (Messner et al. 
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2013), suggest that SR-BI is localized in the basolateral 
membrane of primary human liver microtissues, closely 
mimicking the in vivo situation.
HDL-derived lipids are delivered to BC-like structures
We next assessed the functionality of BC-like structures in 
HepG2 cells with regard to their handling of HDL-derived 
lipids. Therefore, HDL was labeled with either Alexa 488 at 
the apolipoprotein moiety (HDL-Alexa 488) or the fluores-
cent cholesterol analog BODIPY-cholesterol (HDL-BP-C) 
(Li et al. 2006). Alexa 488-labeled HDL was found in close 
proximity to BC-like structures, but almost no co-localiza-
tion with phalloidin was observed (Fig. 1b). This indicates 
that HDL is endocytosed, comes in close contact with the 
apical membrane, and possibly transfers lipids to the apical 
membrane. In contrast, HDL-BP-C was found within BC-
like structures after only 15 min, showing that HDL-derived 
cholesterol is rapidly transported to the apical membrane 
(for serial z-stack images, see Supplementary Fig. 3); simi-
lar findings were reported previously (Wüstner et al. 2004). 
Thus, our results indicate that the BC-like structures formed 
by HepG2 cells are functional in translocating cholesterol 
as HDL-BP-C was clearly detected within these structures.
SR-BI is mainly localized to the sinusoidal membrane 
in rodent liver
We further investigated the localization of SR-BI in vivo in 
murine liver. β-Catenin, which plays an important role in 
Fig. 1  SR-BI localization in vitro and delivery of HDL-derived cho-
lesterol to BC-like structures. a HepG2 cells were either cultivated 
under standard conditions to form a monolayer (upper panel) or 
allowed to form spheroids (lower panel). Immunofluorescence stain-
ing for SR-BI was performed, followed by phalloidin staining. Sphe-
roids were imaged using a confocal microscope; monolayers were 
imaged using a conventional fluorescence microscope. Bar = 40 µm; 
bar for inset = 10 µm. Blue = DAPI. b HepG2 cells were incubated 
with 50 µg/ml of HDL-Alexa 488 (upper panel) or HDL-BODIPY-
cholesterol (HDL-BP-C; lower panel) for the indicated time points. 
Afterward, cells were fixed, and phalloidin staining was performed. 
Cells were imaged using a confocal microscope. Bar = 25 µm; for 
inset bar = 6 µm
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the formation of adherent junctions, was used as a marker 
for the sinusoidal membrane of hepatocytes. SR-BI co-
localized strongly with β-catenin (Fig. 2a, arrowheads). 
In addition, intense SR-BI staining was detected adjacent 
to sinusoidal endothelial cells, which were stained with 
the endothelial cells marker CD31 (Fig. 2b, arrowheads). 
Only a minor amount of SR-BI was expressed at the cana-
licular membrane, as shown by co-staining with the canali-
cular transporter multidrug resistance-associated protein 2 
(MRP2) (Fig. 2c, arrowheads).
Next, we examined whether fasting and refeeding affect 
the localization of SR-BI in mouse liver (Fig. 3). Fasting 
Fig. 2  Immunohistological analysis of SR-BI localization in vivo in 
mouse liver. a–c mouse liver sections were stained for SR-BI (red) 
and either β-catenin (green a), or CD31 (green b), or MRP2 (green c) 
and imaged using a confocal microscope. SR-BI was found beneath 
endothelial cells (arrowheads in b) and to co-localize with β-catenin 
(arrowheads in a) and to some extent with MRP2 (arrowheads in 
c). Bar = 50 µm; for middle panel bar = 10 µm, for lower panel 
bar = 3 µm (a, b) and 1.5 µm (c). Blue = DAPI
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is a powerful stimulator of adipose tissue lipolysis, which 
gives rise to a profound increase in plasma fatty acid con-
tent. These fatty acids are readily taken up by the liver 
and lead to a transient hepatic steatosis, which regresses 
rapidly after refeeding. Marked SR-BI immunostaining 
was observed in the membranes facing the sinusoids in 
livers from ad libitum fed (Fig. 3a), 24-h fasted (Fig. 3b), 
and 24-h fasted/12-h refed mice (Fig. 3c), whereas only 
minor staining was present in the canalicular membranes 
of the hepatocytes. Interestingly, there was an increased 
spotty cellular SR-BI immunoreactivity in the proximity 
of MRP2-positive canalicular membranes in hepatocytes of 
mice fasted for 24 h (Fig. 3b).
To further substantiate the immunofluorescence data, we 
prepared canalicular membranes from rat liver. SR-BI pro-
tein levels were enriched in these membranes over starting 
Fig. 3  Immunohistological analysis of SR-BI localization upon 
fasting and refeeding. a–c, immunofluorescence analysis of SR-BI 
(green) and MRP2 (red) in livers from C57BL/6 J mice fed ad libi-
tum (a), fasted for 24 h (b), and fasted for 24 h and the refed for 
12 h (c) using confocal microscopy. Bar = 50 µm for upper panels. 
Bar = 20 µm for middle and lower panels. CV central vein
652 Histochem Cell Biol (2014) 142:645–655
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material S1 (ninefold), while the LDL receptor (LDLR), 
known to cycle between endosomal compartments and 
the sinusoidal membrane, was not specifically enriched 
(1.6-fold) (Fig. 4). The canalicular marker leucine amino 
peptidase was increased about sevenfold in this membrane 
preparation using both Western blot analysis and enzymatic 
measurements. The enzymatic activities of alkaline phos-
phatase and 5′-nucleosidase, two known canalicular marker 
proteins, were increased by 19- and 21-fold, respectively. 
In contrast, the endosomal/lysosomal marker acid phos-
phatase was depleted in this membrane fraction by 0.8-fold, 
based on enzymatic measurements (Fig. 4b). Thus, our data 
demonstrate that canalicular membranes contain detectable 
amounts of SR-BI protein; however, SR-BI is not as highly 
expressed as classical proteins residing in the canalicular 
membrane such as 5′-nucleosidase and alkaline phosphatase.
SR-BI is primarily found at the sinusoidal membrane 
in human liver
Finally, we investigated the localization of SR-BI in human 
liver (Fig. 5). The bile salt export pump ATP-binding cas-
sette transporter B11 (ABCB11) was used as a marker 
of the apical membrane of hepatocytes. The majority of 
SR-BI was found on the membrane facing the sinusoids, 
whereas only a minor amount was detected at the canalicu-
lar membrane, as shown by co-localization with ABCB11 
(see arrowheads).
Discussion
In this study, we show with immunohistological and bio-
chemical methods that SR-BI is mainly expressed on sinu-
soidal membranes in the liver of rodents and humans. Nev-
ertheless, SR-BI is also detected at canalicular membranes, 
although to a much lesser extent. Interestingly, we observed 
a strong SR-BI staining at the membrane of BC-like struc-
tures in the human hepatoma cell lines HepG2 and Huh7, 
indicating that this cell models differ substantially from the 
in vivo situation. Furthermore, HDL-derived cholesterol 
was found within these BC-like structures in HepG2 cells. 
Microtissues, derived from primary human hepatocytes, 
maintain a SR-BI distribution pattern similar to that found 
in liver even when they were cultivated for up to 28 days.
Even though polarized hepatic cell lines were shown to 
mimic some of the liver-specific properties and functions 
such as bile canaliculi formation (Sormunen et al. 1993; 
Chiu et al. 1990), especially when the cells are cultivated 
in 3D structures (for a review see: Decaens et al. 2008), 
they display considerable differences (Tsukamoto et al. 
2013). We show that there is a significant discrepancy in 
the distribution of SR-BI, which was enriched at the apical 
membrane in cultured HepG2 and Huh7 cells, whereas in 
vivo only a minor amount was associated with canalicular 
membranes. Interestingly, human 3D liver microtissues dis-
played a SR-BI distribution pattern that was very similar to 
the in vivo situation in human and murine liver. Based on a 
previous careful characterization of these liver microtissues 
(Messner et al. 2013), we conclude that, like in the liver, 
SR-BI is mainly localized in basolateral membranes and 
only a minor amount is found in the apical membranes or 
non-parenchymal cells such as Kupffer cells.
HDL-derived BODIPY-cholesterol was efficiently 
transported into the BC-like, MDR1 expressing structures 
formed by HepG2 cells, whereas Alexa-labeled HDL did 
not reach these structures. This is in agreement with pre-
vious reports showing selective sorting of HDL-derived 
lipids and the HDL particle in hepatic cell lines (Wüstner 
2005; Wüstner et al. 2004).
We could clearly demonstrate in vivo that SR-BI is 
associated with canalicular membranes in mice, rats, and 
humans using different experimental approaches. In addi-
tion to immunohistological analyses of livers from chow-
fed mice and healthy humans, we prepared liver canalicular 
membranes from chow-fed rats. SR-BI protein was con-
comitantly enriched with the canalicular marker leucine 
amino peptidase in the canalicular membrane fraction, 
Fig. 4  Biochemical investigation of SR-BI localization in vivo in rat 
liver. a Western blot analysis of starting material, intermediate ali-
quots and final canalicular membranes is shown. S1 supernatant 1; S2 
supernatant 2; SA supernatant A; SB supernatant B; SC supernatant C; 
CM canalicular membrane. b Enrichment of corresponding proteins 
was assessed by densitometric calculation (protein) and measured 
enzymatic activity (enzyme). Note the enrichment of SR-BI in mem-
brane fractions of rat liver representing canalicular membranes
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indicating that some SR-BI is partitioned in bile canalicular 
membranes. In contrast, the LDLR, which cycles between 
endosomes and the sinusoidal membrane, served as a nega-
tive control. Accordingly, LDLR protein was highly abun-
dant in the starting material and gradually decreased dur-
ing the canalicular membrane purification with almost no 
enrichment in the final fraction.
The interaction of SR-BI with proteins containing a PDZ 
domain is crucial for its location (Ikemoto et al. 2000; Tsu-
kamoto et al. 2013; Hu et al. 2013). PDZ domain-contain-
ing protein 1 (PDZK1) is the major determinant of SR-BI 
expression and localization in the liver, which was shown 
to be associated with SR-BI residing in sinusoidal mem-
branes (Ikemoto et al. 2000). In PDZK1 knockout mice, 
hepatic SR-BI is dramatically reduced and redistributed 
from the cell surface of hepatocytes to intracellular regions 
(Fenske et al. 2008). The regulation of SR-BI by PDZK1 
seems to be hampered in hepatocyte cell culture since 
PDZK1, like canalicular markers, is altered in the transition 
process occurring from liver to primary hepatocytes (Tsu-
kamoto et al. 2013).
Another determinant of SR-BI localization, at least 
in vitro, is the cellular cholesterol status. It was reported 
that basolateral–apical transcytosis of SR-BI occurs upon 
cholesterol loading in the polarized hepatocyte cell model 
WIF-B (Harder et al. 2007). In addition, cholesterol deple-
tion triggers basolateral–apical transcytosis of SR-BI in 
MDCK cells (Burgos et al. 2004). These studies were per-
formed in cells that overexpress SR-BI, which may already 
impact SR-BI distribution. In a physiological model of 
metabolic disturbance of the liver, the fasting and refeeding 
situation, where a transient fatty liver status can be seen, 
the overall distribution of SR-BI was unchanged; however, 
some intracellular staining was apparent. This is consist-
ent with previous data showing that the hepatic cholesterol 
content was increased by more than sixfold in mice fed an 
atherogenic diet, and SR-BI expression decreased without 
an obvious change in the cellular expression pattern (Nie-
meier et al. 2009). Furthermore, in estrogen-treated rats, a 
model in which hepatic cholesterol is increased, there was 
no obvious alteration in SR-BI distribution (Stangl et al. 
2002). When canalicular membranes of estrogen-treated 
rats were prepared, a similar SR-BI distribution pattern was 
found as in untreated rats (H. Stangl, unpublished data).
Numerous in vivo studies, which aimed at investigating 
the contribution of SR-BI to biliary cholesterol secretion, 
Fig. 5  Immunohistological 
analysis of SR-BI localization 
in vivo in human liver. Human 
liver sections were stained 
for SR-BI (red) and ABCB11 
(green) and imaged using a 
confocal microscope. Partial 
co-localization of SR-BI and 
ABCB11 was found (arrow-
heads). Bar = 50 µm; for 
middle panel bar = 30 µm, 
for lower panel bar = 6 µm. 
Blue = DAPI
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exploited genetic modification of SR-BI (Kozarsky et al. 
1997; Mardones et al. 2001; Ji et al. 1999; Wiersma et al. 
2009). Hepatic SR-BI overexpression increased biliary cho-
lesterol secretion in mice; conversely, biliary cholesterol 
secretion was decreased in SR-BI knockout mice (Wiersma 
et al. 2009; Mardones et al. 2001). These are convinc-
ing observations, since the majority of cholesterol that is 
destined for secretion into the bile derives from selective 
cholesteryl ester uptake from HDL via SR-BI. It was pre-
viously shown that selective cholesteryl ester uptake from 
HDL into hepatocytes was blocked in SR-BI knockout 
mice (Out et al. 2004), emphasizing the important role of 
SR-BI at the sinusoidal membrane. However, we and oth-
ers (Kozarsky et al. 1997; Ikemoto et al. 2000; Sehayek 
et al. 2003) detected SR-BI at the canalicular membrane 
in rodents and humans. The question remains to which 
extent SR-BI participates in apical cholesterol secretion or 
whether it has other functions at the apical membrane.
Despite fundamental differences in lipoprotein metabo-
lism between rodents and humans, SR-BI loss of function 
has comparable effects at least on HDL cholesterol levels. 
Humans with SR-BI mutations (Brunham et al. 2011) as 
well as SR-BI knockout mice (Covey et al. 2003) display 
increased plasma HDL cholesterol levels, indicating that 
hepatic SR-BI expression in humans is as important as in 
mouse models. Our findings on SR-BI localization in the 
liver provide evidence for a common distribution pattern in 
rodents and humans.
In summary, two important observations arise from the 
present work. First, in vitro cultures of hepatocytes such as 
HepG2 cells show, among other limitations, considerable 
differences in the cellular localization of SR-BI compared 
to the in vivo situation. However, 3D human liver micro-
tissues maintain a SR-BI distribution pattern that is similar 
to human and mouse liver. Thus, in vitro results studying 
SR-BI expression, especially those exploiting SR-BI loss 
or gain of function, should be evaluated with care. Second, 
the vast majority of SR-BI protein in hepatocytes of rodent 
and human liver resides at the sinusoidal membrane; how-
ever, a minor portion is clearly detected at the canalicular 
membrane.
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